Treatment of non-Hodgkin's lymphoma with radiolabeled murine, chimeric, or humanized LL2, an anti-CD22 monoclonal antibody

…, SO Leung, AD Rubin, T Herskovic, D Hanley… - Cancer Research, 1995 - AACR
LL2 is a murine IgG2a anti-CD22 monoclonal antibody found to react with virtually all non-Hodgkin's
lymphomas (NHLs). Twenty-one patients with chemotherapy-resistant NHL …

RNA metabolism in lymphocytes stimulated by phytohemagglutinin: Initial responses to phytohemagglutinin

HL COOPER, AD RUBIN - Blood, 1965 - ashpublications.org
The initial changes in lymphocyte RNA metabolism produced by treatment with
phytohemogglutinin (PHA) are described. The earliest change was a decrease in total RNA (i-RNA), …

Phase I/II trial of 131I‐MN‐14 F(ab)2 anti–carcinoembryonic antigen monoclonal antibody in the treatment of patients with metastatic medullary thyroid carcinoma

…, T Herskovic, M Pereira, AD Rubin… - … Journal of the …, 1999 - Wiley Online Library
BACKGROUND Monoclonal antibodies (MAbs) against carcinoembryonic antigen (CEA) have
been recognized as targeting agents for medullary thyroid carcinoma (MTC). This Phase I/…

Improved detection of medullary thyroid cancer with radiolabeled antibodies to carcinoembryonic antigen.

…, AD Rubin, T Herskovic, D Hanley… - Journal of clinical …, 1996 - ascopubs.org
PURPOSE This investigation was undertaken to assess the targeting of established and occult
medullary thyroid cancer (MTC) with radiolabeled monoclonal antibodies (MAbs) reactive …

[PDF][PDF] Initial experience with high-dose radioimmunotherapy of metastatic medullary thyroid cancer using 131I-MN-14 F (ab) 2 anti-carcinoembryonic antigen MAb …

…, S Suleiman, M Pereira, AD Rubin… - Journal of Nuclear …, 2000 - Soc Nuclear Med
… The time until grade 3 or 4 white blood cell and neutrophil toxicity ranged from 9 to 34 d (median,
22 d), whereas that for platelet toxicity ranged from 16 to 29 d (median, 21 d). The …

[PDF][PDF] Radioimmunotherapy of medullary thyroid cancer with iodine-131-labeled anti-CEA antibodies

…, M Pereira, AD Rubin, D Hanley… - Journal of Nuclear …, 1996 - Soc Nuclear Med
… Przybylowski, D. Varga and L. Ince for prepara tions and quality assurance of the labeled
antibody, S. … Vagg for data manage ment, D. Dunlop for imaging and dosimetry assistance …

Chronic reticulolymphocytic leukemia: Reclassification of “leukemic reticuloendotheliosis” through functional characterization of the circulating mononuclear cells

AD Rubin, SD Douglas, LN Chessin, PR Glade… - The American Journal of …, 1969 - Elsevier
The circulating mononuclear cells that distinguish the disease often called “leukemic
reticuloendotheliosis” have been redefined by recently developed cytologic and functional criteria. …

The delayed response of chronic lymphocytic leukemia lymphocytes to phytohemagglutinin in vitro

K Havemann, AD Rubin - Proceedings of the Society for …, 1968 - journals.sagepub.com
The kinetics of RNA, DNA, and protein synthesis were analyzed in normal and CLL lymphocytes
stimulated by PHA in vitro. Normal cultures exhibited maximal increases in lymphocyte …

Prospects of radioimmunotherapy in epithelial ovarian cancer: results with iodine-131-labeled murine and humanized MN-14 anti-carcinoembryonic antigen …

…, LC Swayne, RM Sharkey, R Dunn, AD Rubin… - Gynecologic …, 1997 - Elsevier
Objectives.Epithelial ovarian cancer (EOC) is known to produce carcinoembryonic antigen (CEA),
and the plasma CEA level is frequently elevated in patients with advanced stage and …

Evolving patterns of RNA metabolism during transition from resting state to active growth in lymphocytes stimulated by phytohemagglutinin.

AD Rubin, HL Cooper - Proceedings of the National …, 1965 - National Acad Sciences
Methods.-Lymphocyte cultures: The technique for obtaining purified lymphocyte suspensions
from humanperipheral blood, and details of culturepreparation have been described. 6 In …